ACTU
ACTU
NASDAQ · Biotechnology

Actuate Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.53
-0.05 (-3.16%)
As of Jun 30, 10:33 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +1,378.4% upside
Low Target $15.82
Average Target $22.62
High Target $24.89
Current Price $1.53
Current
$1.53
Target
$22.62
$15.82 $22.62 avg $24.89
Scenario Analysis
Bear Case
$15.82
934.0%
Low target
Base Case
$22.62
+1,378.4%
Avg target
Bull Case
$24.89
+1,526.8%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$9.22
-83.4% from high
52-Week Low
$1.58
+-3.2% from low
Target vs 52W High
$22.62
+145.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%